The Human Vaccine Industry

Student’s Name

Professor’s Name

Subject

DD Month YYYY

Export Vaccine from Spain to Columbia

Human Vaccines

The general idea that prevention is better than cure has been central to the development of vaccines which have drastically transformed the landscape of human health. Small pox has since been eradicated with polio, bacterial meningitis, measles and rubella on the verge of being eliminated. Moreover, the vaccination against the main viral cause of death due to infantile diarrhea and dehydrations is being disseminated. Therefore, governments promote vaccine production due to the many benefits associated with their use. Apart from averting humanitarian crisis regarding disease outbreak, vaccines reduce the amount government use in public medical care as well as many other associated economic benefits (Partridge et al, 2013). The vaccine industry is therefore important and new companies are sprouting in developing countries in order to provide solutions to major epidemics affecting the population. Generally vaccines are getting immense popularity worldwide due to their efficacy and effectiveness in combating known epidemics. Therefore, the market for vaccines is large due to the huge demand generated by prevalence of preventable diseases on a worldwide scale.

Global Market for Vaccines

The global market for human vaccines is expected to rise to 25 billion US dollars by 2025. The status of the vaccine is changing in the pharmaceutical industry due to the increased awareness of its significance. Moreover, the vaccines are becoming an engine for the pharmaceutical industry. Communicable diseases and the new threats have necessitated reliance on vaccines as a cost effective way of combating epidemics. New funding opportunities from governments, donors, United Nations and foundations have facilitated new research techniques and manufacturing technologies which have led to production of high quality and effective vaccines. Moreover, increasing demand, new target populations and large emerging markets have contributed to the positive trend in the development and growth of human vaccine markets globally.  

The global market for human vaccines shows a positive growth trend with the main markets being the Americas, Asia Pacific and Europe markets. The Americas is the largest human vaccine market due to the high incidences of infectious diseases and cancers in specific regions like US, Canada, and Latin America. Moreover, the region has a large population that generates a high demand for the produced human vaccines. The Americas region is projected to account for more than 45% of the global market by 2020. This implies that the region has a great potential in terms of sustaining an optimal demand for the production of human vaccines.

The Asia Pacific market accounts for 52% of world population. This implies that it has a huge market potential for human vaccine. The region has vast climatic zones most of which have an all year round circulation of influenza virus. Moreover, there is evidence of increased awareness regarding the importance of influenza vaccination. Necessary policies have subsequently been developed to facilitate the introduction of human vaccines in the region due to increased mortality rates in the population. The World Health Organization initiatives for pandemic preparedness have focused on the strengthening of vaccine supply in the region hence creating demand for production and supply of the human vaccines. As a result, WHO has initiated Global Action Plans aimed at facilitating supply of vaccines in the Asia Pacific region.